Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Skin Neoplasms 2Keratosis, Actinic 2Carcinoma, Basal Cell 1

Interventions

pembrolizumab 157Nivolumab 132Ipilimumab 77Cyclophosphamide 46Specimen Handling 44Magnetic Resonance Spectroscopy 39cemiplimab 35Biopsy 31fludarabine 28trametinib 24relatlimab 24binimetinib 23Interleukin-2 21fludarabine phosphate 20dabrafenib 20atezolizumab 20Radiotherapy 20Opdualag 19Radiosurgery 18CTLA-4 Antigen 18encorafenib 17aldesleukin 17Blood Specimen Collection 17avelumab 14Immunoglobulin G 14Disulfides 13lenvatinib 11Bevacizumab 11lifileucel 10Paclitaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Niacinamide × Dermatologic × 1 year × Clear all
NCT07286318 2026-06-05

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

University of Pittsburgh

Phase EARLY_PHASE1 Recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT05702398 2026-03-20

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Rhode Island Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Dermatologic

Skin Neoplasms

NCT07049068 2025-09-15

Comparison of Nicotinamide Treatments for Actinic Keratosis

Federal University of Rio Grande do Sul

Phase 1 Completed
74 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡